Novel approaches to pediatric leukemia treatment. - Wikidata - awgldk - TriplyDB

Novel approaches to pediatric leukemia treatment.

Novel approaches to pediatric leukemia treatment.

http://www.wikidata.org/entity/Q38500371

about

Novel approaches to pediatric leukemia treatment.

http://www.wikidata.org/entity/Q38500371

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Novel approaches to pediatric leukemia treatment.

@en

type

label

Novel approaches to pediatric leukemia treatment.

@en

prefLabel

Novel approaches to pediatric leukemia treatment.

@en

P1433

Q38500371-0156B125-EDB7-4838-837A-6E105F9EF38B

P1476

Q38500371-88DACEAB-10AA-4E1C-8DC9-6E91D780E024

P2093

Q38500371-1BEB5B8B-9107-4A72-ACCC-878DFD1E9F5C

P2860

Q38500371-042F7535-2EB8-4538-950A-BEBDEE102AF0

Q38500371-09AD375C-4BA8-4754-8193-0D5C186D6CC2

Q38500371-0A3CADDF-5044-4D13-9CD2-9471A5B952F2

Q38500371-0F438D92-981C-4A35-8012-C7E05ABCED06

Q38500371-11571B62-1055-412E-B018-6E7AFB3BCB64

Q38500371-125AAA2D-3880-457A-9576-DC2A008A2888

Q38500371-12DEC2DD-ED1A-48BD-8DE7-B6610F94CE12

Q38500371-12E197ED-1B8E-46E9-9C35-952E2A80B614

Q38500371-13840E76-66DC-4FA7-AB81-507E170DF466

Q38500371-13CB8031-398A-400B-AD41-609356A019B9

P304

Q38500371-3222C9B2-727B-48CD-8068-2CCAFE2F7981

P31

Q38500371-5DA41DC6-8774-4E2E-A163-2FBD28090797

P356

Q38500371-1943C3DA-0EDE-4552-8D4B-F22741FCFDDC

P433

Q38500371-49FD12C3-AF7D-4A7C-8B73-C4E226026D30

P478

Q38500371-1FC88E0B-3994-42EC-8E62-16D0EAF2AE26

P577

Q38500371-B80B9A92-440C-481C-8CB2-1928331673B4

P698

Q38500371-FAB121AF-B2BD-46D5-BA9E-67A13FB02076

P356

14737140.2015.1047769

P1433

Expert Review of Anticancer Therapy

P1476

Novel approaches to pediatric leukemia treatment.

@en

P2093

Xavier Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Selective inhibition of BET bromodomains

Structural and functional alterations of FLT3 in acute myeloid leukemia

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia.

Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.

Ponatinib in refractory Philadelphia chromosome-positive leukemias.

Stem cells, cancer, and cancer stem cells

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Bispecific T-cell engaging antibodies for cancer therapy

P304

811-828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2015.1047769

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26004287

http://www.w3.org/2001/XMLSchema#string